Long-term quality of life is not affected by age in AML/MDS patients after allogeneic hematopoietic stem cell transplantation
Year: 2005
Type: article
Study design: Observational Study
Abstract: Objective: Allogeneic hematopoietic stem cell transplantation (alloHSCT) can have significant impact on patients’ quality of life (QOL) in the long term. We seek to describe QOL of long-term survivors with AML/MDS and compare QOL as a function of age at transplant. Methods: Between January 1976 and September 2001, 544 adult AML/MDS patients received alloHSCT at our institution. Long-term survivorship was defined as survival in remission beyond 2 years post-HSCT because failure rate stabilized in the third year.
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2052881736